B. J. Nankivell, R. J. Borrows, C. L. Fung, P. J. O'connell, R. D. Allen et al., The natural history of chronic allograft nephropathy, N Engl J Med, vol.349, issue.24, pp.2326-2333, 2003.

T. R. Srinivas and B. Kaplan, Transplantation in 2011: New agents, new ideas and new hope, Nat Rev Nephrol, vol.8, issue.2, pp.74-75, 2012.

M. C. Londono, R. Danger, M. Giral, J. P. Soulillou, A. Sanchez-fueyo et al., A need for biomarkers of operational tolerance in liver and kidney transplantation, Am J Transplant, vol.12, issue.6, pp.1370-1377, 2012.

K. J. Wood, A. Bushell, and J. Hester, Regulatory immune cells in transplantation, Nat Rev Immunol, vol.12, issue.6, pp.417-430, 2012.

J. Y. Niederkorn, Emerging concepts in CD8(+) T regulatory cells, Curr Opin Immunol, vol.20, issue.3, pp.327-331, 2008.

E. Picarda, I. Anegon, and C. Guillonneau, T-cell receptor specificity of CD8(+) Tregs in allotransplantation, Immunotherapy, vol.3, issue.4, pp.35-37, 2011.

C. Guillonneau, E. Picarda, and I. Anegon, CD8+ regulatory T cells in solid organ transplantation, Curr Opin Organ Transplant, vol.15, issue.6, pp.751-756, 2010.

S. Menoret, C. Guillonneau, S. Bezie, L. Caron, I. Anegon et al., Phenotypic and functional characterization of CD8(+) T regulatory cells, Methods Mol Biol, vol.677, pp.63-83, 2011.

S. Wei, Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells, J Leukoc Biol, vol.88, issue.3, pp.495-505, 2010.

S. Nandi, Receptor-type protein-tyrosine phosphatase zeta is a functional receptor for interleukin-34, J Biol Chem, vol.288, issue.30, pp.21972-21986, 2013.

T. Chihara, IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation, Cell Death Differ, vol.17, issue.12, pp.1917-1927, 2010.

Y. Wang, IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia, Nat Immunol, vol.13, issue.8, pp.753-760, 2012.

M. Chemel, Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients, Ann Rheum Dis, vol.71, issue.1, pp.150-154, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00667486

M. Baud'huin, Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis, J Pathol, vol.221, issue.1, pp.77-86, 2010.

G. P. Spickett, M. R. Brandon, D. W. Mason, A. F. Williams, and G. R. Woollett, MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen, J Exp Med, vol.158, issue.3, pp.795-810, 1983.

E. Xystrakis, I. Bernard, A. S. Dejean, T. Alsaati, P. Druet et al., Alloreactive CD4 T lymphocytes responsible for acute and chronic graftversus

, Eur J Immunol, vol.34, issue.2, pp.408-417, 2004.

E. Xystrakis, Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation, Blood, vol.104, issue.10, pp.3294-3301, 2004.

C. Guillonneau, CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-?, and indoleamine 2,3-dioxygenase, J Clin Invest, vol.117, issue.4, pp.1096-1106, 2007.

F. Powrie and D. Mason, OX-22high CD4

, + T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset, J Exp Med, vol.172, issue.6, pp.1701-1708, 1990.

L. Ordonez, I. Bernard, L. Faqihi-olive, F. E. Tervaert, J. W. Damoiseaux et al., CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients, PLoS One, vol.4, issue.4, p.5287, 2009.

X. L. Li, Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance, J Immunol, vol.185, issue.2, pp.823-833, 2010.

S. Bezie, Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells, PLoS One, vol.10, issue.3, p.119686, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02149009

E. Picarda, MHC-derived allopeptide activates TCR-biased CD8

, + Tregs and suppresses organ rejection, J Clin Invest, vol.124, issue.6, pp.2497-2512, 2014.

H. Lin, Discovery of a cytokine and its receptor by functional screening of the extracellular proteome, Science, vol.320, issue.5877, pp.807-811, 2008.

V. Garceau, Advance: Avian colonystimulating factor 1 (CS9F-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products, J Leukoc Biol, vol.87, issue.5, pp.753-764, 2010.

B. Fancke, M. Suter, H. Hochrein, M. O'keeffe, and . M-csf, Blood, vol.111, issue.1, pp.150-159, 2008.

K. P. Macdonald, The colony-stimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion, J Immunol, vol.175, issue.3, pp.1399-1405, 2005.

G. L. Gilmore and R. K. Shadduck, Inhibition of day-12 spleen colony-forming units by a monoclonal antibody to the murine macrophage/monocyte colony-stimulating factor receptor, Blood, vol.85, issue.10, pp.2731-2734, 1995.

L. Ordonez, A higher risk of acute rejection of human kidney allografts can be predicted from the level of CD45RC expressed by the recipients' CD8 T cells, PLoS One, vol.8, issue.7, p.69791, 2013.

A. Toromanoff, Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle, Mol Ther, vol.16, issue.7, pp.1291-1299, 2008.

L. Texier and L. , Immunoregulatory function of IL-27 and TGF-beta1 in cardiac allograft transplantation, Transplantation, vol.94, issue.3, pp.226-233, 2012.

E. D. Foucher, IL-34 induces the differentiation of human monocytes into immunosuppressive macrophages. antagonistic effects of GM-CSF and IFN?, PLoS One, vol.8, issue.2, p.56045, 2013.

F. O. Martinez and S. Gordon, The M1 and M2 paradigm of macrophage activation: time for reassessment, Rep, vol.6, p.13, 2014.

P. J. Murray, Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, vol.41, issue.1, pp.14-20, 2014.

S. P. Cobbold, Infectious tolerance via the consumption of essential amino acids and mTOR signaling, Proc Natl Acad Sci U S A, vol.106, issue.29, pp.12055-12060, 2009.

P. Riquelme, IFN-gamma-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients, Mol Ther, vol.21, issue.2, pp.409-422, 2013.

I. K. Campbell, M. J. Rich, R. J. Bischof, and J. A. Hamilton, The colony-stimulating factors and collageninduced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF, J Leukoc Biol, vol.68, issue.1, pp.144-150, 2000.

J. A. Hamilton, Colony-stimulating factors in inflammation and autoimmunity, Nat Rev Immunol, vol.8, issue.7, pp.533-544, 2008.

H. Eda, J. Zhang, R. H. Keith, M. Michener, D. R. Beidler et al., Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood, Cytokine, vol.52, issue.3, pp.215-220, 2010.

A. G. Doyle, W. J. Halliday, C. J. Barnett, T. L. Dunn, and D. A. Hume, Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice, Infect Immun, vol.60, issue.4, pp.1465-1472, 1992.

T. Sakurai, N. Wakimoto, M. Yamada, S. Shimamura, and K. Motoyoshi, Effect of macrophage colonystimulating factor (M-CSF) on mouse immune responses in vivo, Immunopharmacol Immunotoxicol, vol.20, issue.1, pp.79-102, 1998.

T. Sakurai, M. Yamada, S. Simamura, and K. Motoyoshi, Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction, Cell Immunol, vol.171, issue.1, pp.87-94, 1996.

D. Duluc, Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells, Blood, vol.110, issue.13, pp.4319-4330, 2007.

D. Hashimoto, Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation, J Exp Med, vol.208, issue.5, pp.1069-1082, 2011.

S. Menoret, Characterization of immunoglobulin heavy chain knockout rats, Eur J Immunol, vol.40, issue.10, pp.2932-2941, 2010.

T. Larcher, Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy, PLoS One, vol.9, issue.10, p.110371, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02164371

Z. Chen, K. Buki, J. Vaaraniemi, G. Gu, and H. K. Vaananen, The critical role of IL-34 in osteoclastogenesis, PLoS One, vol.6, issue.4, p.18689, 2011.

D. Tzachanis, A. Berezovskaya, L. M. Nadler, and V. A. Boussiotis, Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses, Blood, vol.99, issue.4, pp.1465-1473, 2002.

G. Liu, K. Duan, H. Ma, Z. Niu, J. Peng et al., An instructive role of donor macrophages in mixed chimeras in the induction of recipient CD4(+)Foxp3(+) Treg cells, Immunol Cell Biol, vol.89, issue.8, pp.827-835, 2011.

P. G. Holt, M. A. Schon-hegrad, and J. Oliver, MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations, J Exp Med, vol.167, issue.2, pp.262-274, 1988.

M. D. Jose, L. Meur, Y. Atkins, R. C. Chadban, and S. J. , Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection, Am J Transplant, vol.3, issue.3, pp.294-300, 2003.

N. Van-rooijen and A. Sanders, Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications, J Immunol Methods, vol.174, issue.1-2, pp.83-93, 1994.

C. Guillonneau, The role of TNF-related activation-induced cytokine-receptor activating NF-?B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection, J Immunol, vol.172, issue.3, pp.1619-1629, 2004.